FOXN4 Inhibits Breast Cancer Progression By Direct Activation Of P53

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The Forkhead box (Fox) gene family, comprising over 20 members, influences tumor progression.
• The specific role of FOXN4 in carcinogenesis and tumor development remains largely unknown.

Purpose of the Study:

• To investigate the clinical and pathological significance of FOXN4 in breast cancer.
• To elucidate the molecular mechanisms underlying FOXN4's function in breast cancer.

Main Methods:

• Analysis of FOXN4 expression in breast cancer tissues and cell lines.
• In vitro assays (CCK-8, colony formation, wound healing, Transwell) to assess cell proliferation, epithelial-mesenchymal transition, and invasion.
• Chromatin immunoprecipitation and luciferase assays to determine direct promoter binding.
• Quantitative reverse transcription PCR (RT-qPCR) and Western blotting to evaluate gene expression.
• P53 knockdown experiments to confirm functional relevance.

Main Results:

• FOXN4 expression is reduced in breast cancer tissues and cell lines.
• Lower FOXN4 levels correlate with increased tumor size and lymph node metastasis.
• FOXN4 suppresses breast cancer cell proliferation, epithelial-mesenchymal transition, and invasion in vitro.
• FOXN4 directly binds to the P53 promoter and activates P53 expression.
• P53 knockdown reverses the tumor-inhibitory effects of FOXN4.

Conclusions:

• FOXN4 plays a tumor-suppressive role in breast cancer progression.
• FOXN4 exerts its function by directly activating P53.
• FOXN4 represents a potential therapeutic target for breast cancer, acting through P53 modulation.